P&G Endures 'Top-Line Pain' As Portfolio Streamlining Prioritizes Premium Products
This article was originally published in The Tan Sheet
Executive Summary
The firm reports slumps between 1% and 5% across each of its product categories, but also encourages analysts with reports of sometimes significant progress in its "transformation" initiatives in productivity, portfolio, organization and top-line growth.
You may also be interested in...
P&G Eyes Targeted Innovation, China Opportunities Amid Transformation
CFO Jon Moeller drives home that P&G is "operating in a more volatile environment than we ever have" as it continues shedding slow-growth brands. Hair care and grooming are high among the streamlined company's strategic priorities, as well as the US market and China.
In Brief: Revlon Sale?; P&G/Coty Fragrance Transfer; More
SEC filing affirms Revlon is exploring strategic alternatives; Procter & Gamble will transfer 10 fragrance licenses to Coty. More news in brief.
ICCR’s Growing Membership Ensures Diverse Cosmetics Regulatory Perspectives – PCPC
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: